{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:09:48Z","timestamp":1782796188980,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"S9","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1186\/s12859-018-2277-0","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T07:04:54Z","timestamp":1534143894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms"],"prefix":"10.1186","volume":"19","author":[{"given":"Hsin-Yi","family":"Tsao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ying","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Chia-Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"issue":"9","key":"2277_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","volume":"114","author":"EY Chew","year":"1996","unstructured":"Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol. 1996;114(9):1079\u201384.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"2277_CR2","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc14-S014","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014;37(Suppl 1):S14\u201380.","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"2277_CR3","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R, American Diabetes A. Retinopathy in diabetes. Diabetes Care. 2004;27(Suppl 1):S84\u20137.","journal-title":"Diabetes Care"},{"issue":"4","key":"2277_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1001\/archopht.122.4.552","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, Taylor HR, Hamman RF. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552\u201363.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jfma.2012.09.006","volume":"111","author":"YY Huang","year":"2012","unstructured":"Huang YY, Lin KD, Jiang YD, Chang CH, Chung CH, Chuang LM, Tai TY, Ho LT, Shin SJ. Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000-2009. J Formos Med Assoc. 2012;111(11):637\u201344.","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"2277_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archopht.1995.01100090070025","volume":"113","author":"Early Treatment Diabetic Retinopathy Study Research Group","year":"1995","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1995;113(9):1144\u201355.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jfma.2012.09.011","volume":"111","author":"Tien-Jyun Chang","year":"2012","unstructured":"Chang TJ, Jiang YD, Chang CH, Chung CH, Yu NC, Chuang LM. Accountability, utilization and providers for diabetes management in Taiwan, 2000\u20132009: an analysis of the National Health Insurance database. J Formos Med Assoc. 2012;111(11):605\u201316.","journal-title":"Journal of the Formosan Medical Association"},{"issue":"3","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund J, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556\u201364.","journal-title":"Diabetes Care"},{"issue":"7160","key":"2277_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"UK Pospective Diabetes Study Group","year":"1998","unstructured":"UK Pospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703\u201313.","journal-title":"BMJ"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2147\/DMSO.S39093","volume":"6","author":"B Kowall","year":"2013","unstructured":"Kowall B, Rathmann W. HbA for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform? Diabetes Metab Syndr Obes. 2013;6:477\u201391.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"2277_CR11","first-page":"105","volume":"14","author":"SM Hosseini","year":"2009","unstructured":"Hosseini SM, Maracy MR, Amini M, Baradaran HR. A risk score development for diabetic retinopathy screening in Isfahan-Iran. J Res Med Sci. 2009;14(2):105\u201310.","journal-title":"J Res Med Sci"},{"issue":"10","key":"2277_CR12","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00125-011-2257-7","volume":"54","author":"T Aspelund","year":"2011","unstructured":"Aspelund T, Thornorisdottir O, Olafsdottir E, Gudmundsdottir A, Einarsdottir AB, Mehlsen J, Einarsson S, Palsson O, Einarsson G, Bek T, et al. Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia. 2011;54(10):2525\u201332.","journal-title":"Diabetologia"},{"issue":"5","key":"2277_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jdiacomp.2010.12.002","volume":"25","author":"F Semeraro","year":"2011","unstructured":"Semeraro F, Parrinello G, Cancarini A, Pasquini L, Zarra E, Cimino A, Cancarini G, Valentini U, Costagliola C. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabetes Complicat. 2011;25(5):292\u20137.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"2277_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1472-6947-13-106","volume":"13","author":"E Oh","year":"2013","unstructured":"Oh E, Yoo TK, Park E-C. Diabetic retinopathy risk prediction for fundus examination using sparse learning: a cross-sectional study. BMC Med Inform Decis Mak. 2013;13(1):106.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2277_CR15","unstructured":"Ogunyemi O, Kermah D. Machine learning approaches for detecting diabetic retinopathy from clinical and public health records. In: AMIA 2015 Annual Symposium Proceedings, American Medical Informatics Association; 2015, p.983\u201390."},{"issue":"2","key":"2277_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00125-010-1948-9","volume":"54","author":"Q Gong","year":"2011","unstructured":"Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, Li H, Li H, Jiang Y, Shuai Y, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing diabetes prevention outcome study. Diabetologia. 2011;54(2):300\u20137.","journal-title":"Diabetologia"},{"issue":"8","key":"2277_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1001\/jamaophthalmol.2014.859","volume":"132","author":"JC Lin","year":"2014","unstructured":"Lin JC, Shau WY, Lai MS. Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol. 2014;132(8):922\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"2277_CR18","doi-asserted-by":"crossref","unstructured":"Tsao HY, Chan PY, Su ECY. Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms. In: The 13th International Symposium on Bioinformatics Research and Applications (ISBRA 2017). Honolulu: Lecture Notes in Computer Science: Bioinformatics Research and Applications; 2017.","DOI":"10.1186\/s12859-018-2277-0"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-018-2277-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-018-2277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T23:04:25Z","timestamp":1565651065000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-018-2277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":18,"journal-issue":{"issue":"S9","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1186\/s12859-018-2277-0","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"13 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"283"}}